Evidence map›Paper›PMID 42435775›Full record

ArticleUrology2026

Predicting Complications After Radical Nephrectomy With Venous Tumor Thrombectomy and Various IVC Reconstruction Approaches: A Simplified Risk Calculator.

Daniel S Roberson, Spyridon P Basourakos, Madeline Dorr, Daniel D Joyce, Grant M Henning, Matthew T McLeay, Abhinav Khanna, Cornelius A Thiels, Fahad Shuja, Randall R DeMartino and 4 more

Abstract read
In one paragraph

Article in Urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Daniel S RobersonDepartment of Urology, Mayo Clinic, Rochester, MN.
Spyridon P BasourakosDepartment of Urology, Mayo Clinic, Rochester, MN.
Madeline DorrDepartment of Quantitative Health Sciences and Alliance Statistics and Data Management Center, Rochester, MN.
Daniel D JoyceDepartment of Urology, Vanderbilt University Medical Center, Nashville, TN.
Grant M HenningDepartment of Urology, Mayo Clinic, Rochester, MN.
Matthew T McLeayDepartment of Urology, Mayo Clinic, Rochester, MN.
Abhinav KhannaDepartment of Urology, Mayo Clinic, Rochester, MN.
Cornelius A ThielsDivision of Hepatobiliary and Pancreas Surgery, Department of Surgery, Mayo Clinic, Rochester, MN.
Fahad ShujaDivision of Vascular and Endovascular Surgery, Department of Surgery, Mayo Clinic, Rochester, MN.
Randall R DeMartinoDivision of Vascular and Endovascular Surgery, Department of Surgery, Mayo Clinic, Rochester, MN.
John C ChevilleDepartment of Pathology, Mayo Clinic, Rochester, MN.
Stephen A BoorjianDepartment of Urology, Mayo Clinic, Rochester, MN.
Bradley C LeibovichDepartment of Urology, Mayo Clinic, Rochester, MN.
Vidit SharmaDepartment of Urology, Mayo Clinic, Rochester, MN. Electronic address: Sharma.Vidit@mayo.edu.

Funding

Vanderbilt Clinical Oncology Research Career Development ProgramK12CA090625 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Debra L. Friedman, Paula Jill Hurley · 2001 to 2026
$16.9M
NCI NIH HHS K12 CA090625
6 · The paper itself

Abstract

objectiveTo develop an individualized risk calculator for major complications after radical nephrectomy and tumor thrombectomy performed for renal cell carcinoma (RCC).

methodsWe assessed patients who underwent nephrectomy and venous tumor thrombectomy for RCC from 2000 to 2021. The primary outcome was experiencing a high-grade complication within 30 days of surgery. A LASSO logistic regression model screened variables to identify predictors of major complications, which were subsequently used to create a nomogram.

resultsAmong 617 patients, high-grade complications occurred in 9.2% of patients and increased with the increasing cephalad extent of VTT: 4.7% (renal vein only), 11.6% (IVC), and 30.8% (supradiaphragmatic), P <.001. The 30-day mortality rate was <1%. In patients with thrombus extending into the IVC or higher, there was no difference in high-grade complication rates with primary closure, patch venoplasty, tube graft replacement, or IVC ligation. The variables with the highest discriminative ability to predict major complications were: thrombus level, concurrent surgery, and ECOG performance status. These variables were used to develop a nomogram that had an AUC = 0.69 in the development cohort (70%) and AUC = 0.77 in the validation cohort (30%).

conclusionThrombus level, anticipated concurrent surgery, and patient performance status, though not IVC reconstruction technique, were associated with major complications in the first 30 days after surgery. Our internally validated, parsimonious nomogram predicting major complications after nephrectomy for RCC with VTT may aid surgeons in patient selection and individualize preoperative counseling.

Indexed as

Carcinoma, Renal CellKidney NeoplasmsNeoplastic Cells, CirculatingNephrectomyPostoperative ComplicationsThrombectomyVena Cava, InferiorAgedFemaleHumansMaleMiddle AgedNomogramsPlastic Surgery ProceduresRetrospective StudiesRisk Assessment

Identifiers

PMID42435775
PMCPMC13572985

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.